ZURICH, June 29 (Reuters) - Rival cancer cell therapies from Swiss drugmaker Novartis and U.S.-based Gilead Sciences won a key recommendation from a European Medicines Agency panel, likely clearing their way for approval within months.


30


Reuters

Latest News

NewYorkTimes: Maxim Dadashev Dies of Injuries After Losing Boxing Match

WashingtonPost: Nicaragua court frees prisoner in death of Brazilian student

ABC: Who are the men in white behind Hong Kong's mob attack?

ABC: Red Sox move into 2nd place for 1st time since March

ABC: Turner hits for 2nd cycle, Nationals rout Rockies 11-1

ABC: Turner hits for 2nd cycle, Nationals rout Rockies 11-1

Times of Israel: Man killed in apparent mob-related car explosion in Tel Aviv

FOX: Rudy Giuliani slams Mayor Bill de Blasio over videos of NYPD being sprayed with water

FOX: Ingraham: The culture of disrespect

FOX: Police union president demands resignation of NYPD commissioner after recent attacks on cops

FOX: Candace Owens: Victimhood has become a mental plague on black America

CNN: Don Lemon: No obstruction, no collusion? Not true.

ABC: Duda homers, leads Royals to 5-4 win over first-place Braves

Los Angeles Times: What's on TV Wednesday: 'South Side' on Comedy Central and BET

Los Angeles Times: Placing bets at Dodger Stadium part of the $100-million renovation plans

USA Today: Climate activists glue themselves to Capitol entrances to pressure lawmakers

USA Today: LEADING OFF: Minor, Stroman start on deadline radars

USA Today: Smoak homers, gets winning hit as Blue Jays top Indians 2-1

USA Today: Amazon, Realogy team up to help you buy your next house and get free stuff in the process

USA Today: Forever 21 sent Atkins diet bars with plus-sized orders, calls it 'oversight'

Daily Mail: Video: Julie Goodwin weighs in on the MasterChef situation

Daily Mail: Video: Chris Pratt reveals to Extra he met wife Katherine at church

Daily Mail: Cargo pants are the daggy fashion trend from the 90s set to make a comeback

15 Related Articles from 2018-06-23